文献速递鼻科

内镜鼻窦手术后阿片类药物使用与镇痛需求的随机临床试验评估

Assessment of Opioid Use and Analgesic Requirements After Endoscopic Sinus Surgery: A Randomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2021-01-01

这项多机构、非盲随机临床试验比较内镜鼻窦手术后两种镇痛方案:对乙酰氨基酚基础上,二线用羟考酮或布洛芬。结果显示多数患者仅用非阿片方案即可充分镇痛,布洛芬二线未减少总体麻醉药消耗,但两组麻醉药使用均低。

要点

  • 多数内镜鼻窦手术患者术后仅用对乙酰氨基酚或联合布洛芬即可充分镇痛。
  • 布洛芬作为二线治疗未减少总体麻醉药消耗量。
  • 两组术后疼痛视觉模拟评分相似,非使用者疼痛评分更低。

核心结论

  • 多数内镜鼻窦手术患者术后可采用非阿片方案(单用对乙酰氨基酚或联合布洛芬)治疗。
  • 布洛芬作为二线治疗未减少总体麻醉药消耗,但两组麻醉药使用均低。

研究设计与样本

  • 多机构、非盲随机临床试验,在美国和加拿大6个三级中心开展,纳入因急或慢性鼻窦炎行内镜鼻窦手术的参与者。
  • 共118例患者随机分组:羟考酮救援组62例(52.5%),布洛芬救援组56例(47.5%);平均(SD)年龄46.7(16.3)岁;女性44例(44.0%);白人83例(83.0%),黑人7例(7.0%),亚裔7例(7.0%)。
  • 排除失访和不依从后,羟考酮救援组51例,布洛芬救援组49例。

主要发现

  • 布洛芬救援组中18例(16%)仅需对乙酰氨基酚,28例(57%)仅用对乙酰氨基酚和布洛芬,剩余13例(26%)使用1剂或以上羟考酮。
  • 两组平均对乙酰氨基酚用量相似(9.69 vs 7.96剂;差值1.73;95%CI -1.37至4.83)。
  • 两组平均羟考酮用量相似(1.89 vs 0.77剂;差值1.13;95%CI -0.11至2.36)。
  • 两组术后视觉模拟评分相似;亚组分析显示非阿片使用者在多个术后时间点疼痛评分临床显著更低。

临床怎么用

  • 内镜鼻窦手术后可优先考虑非阿片镇痛方案,如对乙酰氨基酚单用或联合布洛芬。
  • 布洛芬作为二线治疗虽未减少麻醉药消耗,但可作为减少阿片使用的合理选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The opioid epidemic has generated interest in optimizing opioid prescribing after common surgeries. Recent studies have shown a broad range of analgesic prescription patterns following endoscopic sinus surgery (ESS). OBJECTIVE: To compare the efficacy of different analgesic regimens after ESS. DESIGN, SETTING, AND PARTICIPANTS: This multi-institutional, nonblinded randomized clinical trial was conducted at 6 tertiary centers across the US and Canada and included participants who underwent ESS for acute or chronic rhinosinusitis. The study was conducted from March 2019 to March 2020, and the data were analyzed in November to December 2020. INTERVENTIONS: All participants received acetaminophen, 650 mg, as the first-line analgesic. From there, patients were randomized to either oxycodone rescue (oxycodone, 5 mg, as second-line therapy) or ibuprofen rescue (ibuprofen, 600 mg, as second-line therapy, with oxycodone, 5 mg, reserved for breakthrough pain). MAIN OUTCOMES AND MEASURES: Baseline characteristics and disease severity were collected at enrollment. Medication logs, pain scores, and epistaxis measures were collected until postoperative day 7. The primary outcome was the postoperative visual analog scale score for pain. Brief Pain Inventory Pain Severity and Pain Interference Scores were also collected. RESULTS: A total of 118 patients were randomized (62 [52.5%] oxycodone rescue, 56 [47.5%] ibuprofen rescue; mean [SD] age, 46.7 [16.3] years; 44 women [44.0%]; 83 White [83.0%], 7 Black [7.0%], and 7 Asian individuals [7.0%]). After exclusions for loss to follow-up and noncompliance, 51 remained in the oxycodone rescue group and 49 in the ibuprofen rescue group. The groups had similar demographic characteristics and disease severity. Thirty-two (63%) in the oxycodone rescue group had adequate pain management with acetaminophen only, while 19 (37%) consumed at least 1 oxycodone dose. In the ibuprofen rescue group, 18 (16%) required only acetaminophen, 28 (57%) used only acetaminophen and ibuprofen, and the remaining 13 (26%) consumed 1 or more oxycodone doses. The groups had similar average acetaminophen (9.69 vs 7.96 doses; difference, 1.73; 95% CI, -1.37 to 4.83) and oxycodone (1.89 vs 0.77 doses; difference, 1.13; 95% CI, -0.11 to 2.36) use. Both groups had similar postoperative visual analog scale scores. A subanalysis that compared opioids users with nonusers showed clinically significant lower pain scores in nonusers at multiple postoperative points. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, most patients who underwent ESS could be treated postoperatively using a nonopioid regimen of either acetaminophen alone or acetaminophen and ibuprofen. Ibuprofen as a second-line therapy did not reduce overall narcotic consumption, but the overall narcotic use was low in both groups. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03783702.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Ayoub NF, Choby G, Turner JH, et al. Assessment of Opioid Use and Analgesic Requirements After Endoscopic Sinus Surgery: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 34351376. doi:10.1001/jamaoto.2021.1839

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。